Cardiovascular risk in Chinese patients with chronic kidney diseases: Where do we stand?

Chinese Medical Journal

Volumn 118, Issue 11, 2005, Pages 883-886

  Hou, Fan Fan ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Chronic kidney disease; Epidemiology

Indexed keywords

ANEMIA; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; CALCIUM METABOLISM; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; CHRONIC KIDNEY DISEASE; COMORBIDITY; EDITORIAL; HUMAN; MORBIDITY; MORTALITY; PHOSPHATE METABOLISM;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; RISK FACTORS;

EID: 20944437056     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (22)

1. Dialysis and Transplantation Registration Group, Chinese Society of Nephrology. The report about the registration of dialysis and transplantation in China 1999. Chin J Nephrol (Chin) 2001;17:77-78.
2. Shanghai Cooperation Group of Cardiovascular Complications in Nephropathy. The epidemiological survey of cardiovascular disorder in chronic renal failure in Shanghai. Chin J Nephrol (Chin) 2001;17:91-94.
3. Hou FF, Ma ZG, Mei CL, et al. Cardiovascular disease in Chinese chronic kidney diseases patients-I epidemiological survey. Natl Med J China (Chin) 2005;86:458-463.
4. Wu ZS, Yao CH, Zhao D, et al. Multiprovincial monitoring of the trends and determinants in cardiovascular diseases (Sino-MONICA project)-I morbidity and mortality monitoring. Chin J Cardiol (Chin) 1997;25:6-11.
5. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Eng J Med 1998;339:799-805.
6. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. US renal data system, USRDS 1997 annual data report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1997. (Accessed September 15, 2003 at: http//www.usrds.org/adr_1997.htm.)
7. Wilson PWF, D ' Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
8. Foley RN, Parfrey PS, Harnett JD, et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995;5: 2024-2031.
9. Wong JS, Port FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999;55:2515-2523.
10. Yu YM, Hou FF, Zhang X, et al. Hyper-homocysteinemia, oxidative stress and micro-inflammation in chronic renal failure: their roles in atherogene. Chin J Intern Med (Chin) 2004;43:292-295.
11. Hou FF, Guo ZJ, Liang M, et al. Advanced glycation end products stimulate human endothelial cells to produce MCP-1 via activation of p38-MAPK pathway. J Am Soc Nephrol 2003;14.622A.
12. Hou FF, Ren H, Guo ZJ, et al. Enhanced expression of receptor for advanced glycation end products: A novel mechanism for monocyte activation in chronic renal failure. J Am Soc Nephrol 2004;15:1889-1896.
13. Hou FF, Ma ZG, Mei CL, et al. Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients. Natl Med J China (Chin) 2005;85:753-759.
14. Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996;28: 53-61.
15. Jiang JP, Hou FF, Gao LZ, et al. Improvement and reversion of left ventricular hypertrophy by erythropoietin therapy in patients with chronic renal insufficiency. Chin J Intern Med (Chin) 2005;44:25-29.
16. Mann JF, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 2001;134:629-636.
17. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153.
18. Chan JC, Wat NM, So WY, et al. Renin angiotensin aldosterone system blockage and renal disease in patients with type 2 diabetes: An Asian perspective from the RENAAL study. Diabetes Care 2004;27:874-879.
19. Zhang X, Zhang GH, Hou FF. Can ACEI be used in chronic kidney disease patients with serum creatinine level higher than 3 mg/dl? J Am Soc Nephrol 2004;15: 58A.
20. Beijing Dialysis and Transplantation Registration Group. The report about the registration of dialysis and transplantation in Beijing 1999. Chin J Nephrol (Chin) 2001;17:79-82.
21. Shanghai Dialysis and Transplantation Registration Group. The report about the registration of dialysis and transplantation in Shanghai 1999. Chin J Nephrol (Chin) 2001;17:8-5.
22. Jiang JP, Hou FF, Zhang X, et al. Tuberculosis in chronic renal failure patients with or without renal replacement therapy. Med J Chin PLA (Chin) 2002; 27:1038-1040.